WE ARE WHAT WE DO · SO SEE WHAT WE ARE DOING
ND PHARMA & BIOTECH RESEARCH SCIENTISTS HELPING FIGHT CHRONIC DIARRHEA, INFLAMMATORY BOWEL SYNDROME AND OTHER COLO-RECTAL DISEASES THRU HUMAN MICROBIOME RESEARCH AND BACTERIAL FECAL MICROBIAL CULTURE TRANSPLANTATION THAT IS CHANGING PRACTICES.
Cutting-Edge Research adds to medical knowledge and will change medical practice and promising radical cure to diarrhea sufferers, throughout Bacterial Fecal Microbial Culture Transplantation.(BMFCT).
Research Scientists at one of the ND Pharma & Biotech´s associated clinic and Hospital in Chicago, USA, has conducted and summarize the protocol for Bacterial Fecal Transplantation from healthy donors of fecal bacteria, within an extensive program of research about new groundbreaking medical clinical strategies and therapies against diarrhea, chronic, sub-chronic, acute and sub-acute, especially those caused by Clostridium Difficile class-like bacterias. A number of pilot transplantations were made with a cure rate of 98% of monitored patients, most of them volunteers, that reported a complete satisfaction after the procedure and the emotion of recovery of a healthy and disease-free life.
ND Pharma & Biotech associated scientists are members of an extensive Biotechnology program co-funded by the National Institutes of Health that are researching and identified the gene sequences and other relevant data about the number of bacterias living within human organism and their implications in human health and disease. This scientific team, has co-participated in the Human Oral Microbiome Project, that has created and classified an extensive Microbiome Library of more than 300 species living within human oral cavity, with their complete sequencing processes.
The average American gets diarrhea at least once a year – more for some people with chronic bowel conditions such as Irritable Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS), who can suffer it on a daily basis. Hundreds of different microbes, ranging from parasites to bacteria to viruses, can cause these uncomfortable bouts of runny, watery stool. One such popular bacteria is called Clostridium Difficile, or C. diff for short. This nasty spore-like bacteria naturally lives in your colon. However, an overgrowth of C. diff leads to chronic, liquid stool and painful stomach cramps that must be treated by antibiotics to kill it off. That was, at least, until the 21st century. During a fecal transplant procedure, stool is collected from the intestine of a healthy person and transplanted into the intestine of someone suffering from a chronic disease, such as C. diff or irritable bowel syndrome.
The premise of fecal transplants lies with the fact that healthy adults have specific microbes in their colon that ill people do not possess. Their colons are filled with "good bacteria" that can help put a stop to the unhealthy bacteria that are wreaking havoc on your body. Scientists state that the diarrhea, nausea, and stomach pains associated with these illnesses may actually be nothing more than a bacterial overgrowth – of the bad kind. Taking stool from a healthy adult, promote growing and transplanting it into the intestines of someone who suffers a chronic disease or infection – such as irritable bowel disease or recurrent Clostridium Difficile infections – can help stop recurrent flare ups and stop the clostridium bacteria in its tracks.
Welcome to ND NEWS.
ND Pharma & Biotech isa biopharmaceutical, biotechnological and global chemical company focused on the rapid development of industry solutions for diverse fields and sectors from healthcare, medicine and life Sciences to food & nutrition, agriculture and other resources. With a Portfolio of + 187.500 Product References, we are a truly global company proudly operating worldwide.
To Get in touch, please write to: firstname.lastname@example.org
© 2017 The ND Pharma & Biotech Company.
ND Pharma & Biotech is a Company Limited by Shares Registered in England & Wales.
ALL RIGHTS RESERVED.